Affiliation:
1. North-Caucasus Federal University
Abstract
Lactulose is a prebiotic that has found a wide application in medicine and food industry. Commercial lactulose is usually synthesized by isomerization in alkaline media at high temperatures. Enzymatic methods offer a more sustainable alternative and require more moderate processing conditions.
This review covers 44 years of scientific publications (1978–2022) on the enzymatic synthesis and purification of lactulose. The materials were retrieved from Scopus, Web of Science, PubMed, and Elibrary databases.
The enzymatic approach to lactose-to-lactulose conversion has two methods: isomerization (direct) and transgalactosylation (via hydrolysis). Isomerization exploits cellulose-2-epimerases, but their safety status is still rather vague. As a result, cellulose-2-epimerases are not commercial. Epilactose is a by-product of isomerization. Transgalactosylation involves β-galactosidases with an official international safety status (GRAS). It is available on the market, and its action mechanism is well understood. This article systematizes various data on the conditions for obtaining the maximal yields of lactulose by different enzymes.
The Kluyveromyces lactis yeast and the Aspergillus oryzae mold are the main sources of β-galactosidases in lactulose production. The yield can reach 30% if the processing conditions are optimal. Fructose remains the main problem in the production process. No scientific publications revealed a direct relationship between the maximal yields of lactulose and the molar fructose-tolactose ratios. Cellobiose epimerases make it possible to achieve high yields of lactulose (70–80%). However, these enzymes are associated with genetic engineering and mutagenesis, which challenges their safety status. The most promising trends in lactulose biotechnology include secondary dairy raw materials, immobilized enzymes, membrane reactors, complex production processes, lactose-to-lactulose conversion, and purification of final product.
Publisher
Kemerovo State University
Subject
Industrial and Manufacturing Engineering,Economics, Econometrics and Finance (miscellaneous),Food Science
Reference98 articles.
1. Ryabtseva SA, Khramtsov AG, Budkevich RO, Anisimov GS, Chuklo AO, Shpak MA. Physiological effects, mechanisms of action and application of lactulose. Problems of Nutrition. 2020;89(2):5–20. (In Russ.). https://doi.org/10.24411/0042-8833-2020-10012, Ryabtseva SA, Khramtsov AG, Budkevich RO, Anisimov GS, Chuklo AO, Shpak MA. Physiological effects, mechanisms of action and application of lactulose. Problems of Nutrition. 2020;89(2):5–20. (In Russ.). https://doi.org/10.24411/0042-8833-2020-10012
2. Ait-Aissa A, Aider M. Lactulose: Production and use in functional food, medical and pharmaceutical applications. Practical and critical review. International Journal of Food science and Technology. 2014;49(5):1245–1253. https://doi.org/10.1111/ijfs.12465, Ait-Aissa A, Aider M. Lactulose: Production and use in functional food, medical and pharmaceutical applications. Practical and critical review. International Journal of Food science and Technology. 2014;49(5):1245–1253. https://doi.org/10.1111/ijfs.12465
3. Hiraishi K, Zhao F, Kurahara L-H, Li X, Yamashita T, Hashimoto T, et al. Lactulose modulates the structure of gut microbiota and alleviates colitis-associated tumorigenesis. Nutrients. 2022;14(3). https://doi.org/10.3390/nu14030649, Hiraishi K, Zhao F, Kurahara L-H, Li X, Yamashita T, Hashimoto T, et al. Lactulose modulates the structure of gut microbiota and alleviates colitis-associated tumorigenesis. Nutrients. 2022;14(3). https://doi.org/10.3390/nu14030649
4. Chen H-B, Su X-Y. Efficacy and safety of lactulose for the treatment of irritable bowel syndrome. Medicine. 2019;98(39). https://doi.org/10.1097/MD.0000000000017295, Chen H-B, Su X-Y. Efficacy and safety of lactulose for the treatment of irritable bowel syndrome. Medicine. 2019;98(39). https://doi.org/10.1097/MD.0000000000017295
5. Kishor C, Ross RL, Blanchard H. Lactulose as a novel template for anticancer drug development targeting galectins. Chemical Biology and Drug Design. 2018;92(4):1801–1808. https://doi.org/10.1111/cbdd.13348, Kishor C, Ross RL, Blanchard H. Lactulose as a novel template for anticancer drug development targeting galectins. Chemical Biology and Drug Design. 2018;92(4):1801–1808. https://doi.org/10.1111/cbdd.13348